Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.99
+0.88 (6.24%)
At close: Dec 20, 2024, 4:00 PM
15.11
+0.12 (0.80%)
After-hours: Dec 20, 2024, 5:39 PM EST
Arcutis Biotherapeutics Employees
Arcutis Biotherapeutics had 296 employees as of December 31, 2023. The number of employees increased by 28 or 10.45% compared to the previous year.
Employees
296
Change (1Y)
28
Growth (1Y)
10.45%
Revenue / Employee
$468,608
Profits / Employee
-$660,591
Market Cap
1.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 296 | 28 | 10.45% |
Dec 31, 2022 | 268 | 121 | 82.31% |
Dec 31, 2021 | 147 | 93 | 172.22% |
Dec 31, 2020 | 54 | 25 | 86.21% |
Dec 31, 2019 | 29 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 18,000 |
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
10x Genomics | 1,259 |
Clover Health Investments | 552 |
BioCryst Pharmaceuticals | 536 |
Dynavax Technologies | 408 |
RxSight | 374 |
ARQT News
- 14 days ago - Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up? - Seeking Alpha
- 6 weeks ago - Arcutis Biotherapeutics, Inc. (ARQT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4 - Benzinga
- 2 months ago - Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older - GlobeNewsWire
- 3 months ago - New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types - GlobeNewsWire